Plasma renin activity was measured in samples collected in lithium heparin, sodium heparin, and ethylenediaminetetraacetate. The samples were incubated under two widely used sets of conditions to generate angiotensin J, and the results were compared.
Under certain incubation conditions, the absence of ethylenediaminetetraacetate from the sample tube produced low plasma renin activity values. This was obviated by using an alternative incubation medium and was not, therefore, due to direct inhibition of renin by heparin. These lower values were not seen in samples from patients receiving captopril. This suggests that the discrepant values were due to some angiotensin J conversion to angiotensin II and lower homologues in the incubates.
Sodium heparin samples compared closely with lithium heparin samples, indicating that the presence of lithium is not significant.
These results show that, provided the incubation conditions are suitably modified, samples collected into lithium or sodium heparin can be used for measurement of plasma renin activity.
In our laboratory, routine estimation of plasma renin activity (PRA) by radioimmunoassay was found to produce a lower reference range of values than those quoted by other centres.v:" even those using similar Materials and methods methods and primary reagents obtained from an identical source." The one obvious difference in procedure in this laboratory from generally accepted and recommended protocols was that the plasma samples were taken into lithium heparin not ethylenediaminetetraacetate (EDTA). It was, therefore, possible that either heparin or lithium inhibited renin at the concentrations employed,7-9 or the inhibitor mixture used in these estimations was inadequate to prevent some of the angiotensin T formed during the incubation being broken down in the absence of EDTA which, in addition to being an anticoagulant, is a known inhibitor of angiotensinconverting enzyme.'? 11 We now report studies of fresh samples collected and subdivided into tubes containing EDTA, INCUBATION PROCEDURES lithium heparin, and sodium heparin. These were Portions of the samples were incubated at 37°e for compared in the two different but widely used sets of 2--4 hours at pH 5·7 with equal volumes of buffer to incubation conditions to assess their relative generate angiotensin I under two sets of conditions. efficiency. In addition, a small study on the in vitro Firstly, O·IM citric acid/potassium citrate buffer effects of therapeutic doses of captopril, an in vivo in the presence of 8·6 mmol/l 8-hydroxyquinoline 217 sulphate and 4·7 % (vIv) of a saturated ethanolic solution of phenylmethylsulphonylfluoride (PMSF) was used. This procedure-s will subsequently be referred to as PMSFQ. The second medium, as supplied with the CIS RENK angiotensin I kit (CIS (UK) Ltd, Finchley, London), comprised a mixture of 8·0 flomol/l 2-3 dimercaptopropanol (HAL) and 4 mmol/l 8-hydroxyquinoline sulphate buffered in O·IM phosphate. This procedure is referred to as HALQ hereafter.
After the prescribed period of incubation, the samples were frozen at -20°C until required for radioimmunoassay. The unincubated sample portions (angiotensin blanks) were also treated with these inhibitor mixtures but, instead of incubation at 37°C, were stored at~20°C throughout the incubation time and afterwards until required for radioimmunoassay.
RADIOIMMUNOASSA Y
Samples and angiotensin blanks were assayed by both the HALQ procedure (CIS, UK) and by an 'in-house' assay procedure based upon the same primary reagents.P Both assays utilised a 24-hour incubation at 4°C to equilibrate the reactants, followed by a charcoal separation of bound and free fractions.
STATISTICS

Linear regression analysis was performed with x
(from y = a + bx) as the independent variable. The slope (b) and intercept (a) are given (± one SEM). Paired t-tests were used to evaluate the data where appropriate.
Results
EDTA HEPARIN STUDY
PRA values for 18 samples collected into lithium heparin and EDTA were compared when generated in PMSFQ and HALQ. In order to produce a Gaussian distribution, statistical calculations were performed on log-transformed data.
There were no significant differences between the PRA values (paired t-tests, P> ·05) when either PMSFQ or HALQ was used with EDTA, or when PMSFQ was used with heparin. For samples collected into heparin, however, the PRA values were significantly lower in the HALQ samples than in any of the other groups (p = 0·0033, 0·0005, 0·0001). Linear regression analysis of the data for the heparinised samples in HALQ as a function of PMSFQ showed consistently and significantly lower results in the former (r = 0·92, p<·OOl, b = 0·60 ± 0·06, a = 0·20 ± 0·33).
Roulston, Wathen, Sanger, and Muir
COMPARISONS OF LITHIUM AND
SODIUM HEPARIN
The PRA values obtained in four samples collected in lithium heparin were compared with the corresponding values in sodium heparin, for samples incubated in both HALQ and PMSFQ. Paired t-tests on log-transformed data indicated no significant difference (p >0·05) between PRA values from lithium and sodium heparin-collected samples in either HALQ or PMSFQ. Comparison of PMSFQ values for PRA with their HALQ counterparts showed a significantly higher PRA in PMSFQ for both lithium and sodium heparin (p = <0·05 in both cases).
STUDIES WITH CAPTOPRIL
Five samples collected into lithium heparin from subjects receiving oral captopril therapy (37·5-112·5 mg per day) were assayed in parallel with their EDTA counterparts using both the HALQ incubation medium and the PMSFQ medium. No discrepancy between the sets of values was apparent from paired t-tests (t = 0·7508, P = 0·49 for HALQ; t = -1·6938, p=0·17 for PMSFQ).
Discussion
Analysis of the EDTA heparin study appears to confirm that the discrepancy in PRA values lies in the HALQ-generated heparinised plasma specimens. Data comparison shows a significantly lower set of PRA values using the HALQ procedure on heparinised samples than the corresponding values using the PMSFQ procedure. The EDTA samples, however, show directly comparable values for both HALQ and PMSFQ sample incubates, and these are not significantly different from the PMSFQ heparin results. This indicates that the lower values are not due to heparin inhibition of renin but suboptimal inhibition, by HALQ, of converting enzyme.
Comparison of lithium and sodium heparin indicates that both these monovalent cations were equally satisfactory in the renin reaction under either set of incubation conditions. From the small study done with patients on oral captopril therapy, it appears that captopril is able to offset the absence of EDTA in the HALQ system. There are two possible explanations for this, both of which could contribute significantly. First, at high levels of angiotensin I generation, the catabolic processes still presumed to be present in heparinised plasmas with the HALQ procedure become negligible with respect to the total generated amount. Second, the extra inhibition of angiotensin I breakdown afforded by the capropril in vitro may compensate for the lack of EDTA.
In conclusion, an inhibitor system is required that fulfils the criteria of optimal angiotensin I generation, and which is independent of whether the sample is col1ected into EDTA or heparin. The mixture of PMSF and 8-hydroxyquinoline sulphate in citrate buffer appears to fulfil these criteria.
